Company Filing History:
3 out of 3 
2 out of 495 
Years Active: 2019-2024
Title: Frantz Le Dévédec: Innovator in Drug Release Technologies
Introduction
Frantz Le Dévédec, based in Toronto, Canada, is a notable inventor recognized for his contributions to drug delivery systems. With two patents to his name, he has focused on innovative solutions that enhance the efficiency of drug release in biomedical applications. His work blends cutting-edge materials science with medicinal applications, showcasing his commitment to improving patient outcomes through technology.
Latest Patents
Frantz's latest patents delve into controlling drug release in cross-linked poly(valerolactone) based matrices. One significant patent outlines a method that involves polymerizing valerolactone residues, allylvalerolactone, and polyethylene glycol in the presence of a non-metal catalyst. This process produces a copolymer that can effectively control drug release through crosslinking. Additionally, he has devised a method for producing crosslinked particles, designed to store and release drugs over extended periods—specifically ranging from 1 to 6 months following surgical applications. These innovative particles can be composed of polyester backbones and can significantly enhance the therapeutic efficacy of drugs by facilitating controlled release mechanisms in vivo.
Career Highlights
Frantz has made substantial contributions through his work at several institutions, including Pendant Biosciences, Inc. and the Governing Council of the University of Toronto. His research has placed him at the forefront of developing drug delivery systems that are not only effective but also versatile in their application, indicative of his deep understanding of material and pharmaceutical sciences.
Collaborations
Throughout his career, Frantz has collaborated with esteemed colleagues, including Christine Allen and David M. Stevens. Their collective expertise has contributed to advancing the field of drug delivery science, fostering an environment of innovation and collaboration that benefits healthcare.
Conclusion
Frantz Le Dévédec exemplifies the innovative spirit of contemporary inventors dedicated to improving drug therapies. His patents on drug release technologies represent significant advancements in the field, with the potential to improve surgical outcomes and patient care. Through his career highlights and collaborations, Frantz continues to contribute vital knowledge and technologies that promise to shape the future of medical treatments.